HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rep. Pallone Seeks Answers In Tween Makeup Asbestos Controversy

This article was originally published in The Rose Sheet

Executive Summary

The New Jersey congressman has taken a renewed interest in cosmetics safety issues of late, now requesting information from tween-focused retailer Justice about its ingredient sourcing and safety assurance practices, following a report linking one of its makeup products to asbestos contamination. The controversy could fuel the cosmetics reform conversation Pallone is working to kindle in Congress.

You may also be interested in...



US FDA’s Cosmetics Director Katz Cites Fragrance Allergens, Talc-Containing Products Among Priorities

Linda Katz, director of the US FDA’s Office of Cosmetics and Colors, offered insight into priority cosmetics issues at the Independent Beauty Association’s virtual FDA Cosmetic Regulations Workshop.

FDA ‘Actively Investigating’ Asbestos In Cosmetics; Claire’s Rebuts New Allegations

Health Canada’s investigation cleared Claire’s makeup previously linked to asbestos by Scientific Analytical Institute, the same lab whose asbestos findings Tween Brands disputed last year before launching a recall based on its own testing. Cosmetics manufacturers using talc should try to keep up.

Rep. Pallone's Push For Cosmetics Reform Falls Flat During OTC Monograph Bill Markup

The New Jersey Democrat introduced multiple cosmetics-related amendments during the House Health Subcommittee's markup of draft OTC monograph reform legislation. While ultimately nothing came of the proposed measures, it's clear that Pallone remains intent on updating cosmetics regulations to require facility registration, adverse event reporting and good manufacturing practices, among other aims.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel